Voglibose (0.3mg) + Repaglinide (0.5mg)
Volga R 0.5mg/0.3mg Tablet is used in the treatment of type 2 diabetes.
1 Strip of 10 Tablet
Image shown is a representation and may slightly vary from the actual product. Every effort is made to maintain accuracy of all information displayed.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Volga R 0.5mg/0.3mg Tablet is to be taken with food.
Volga R 0.5mg/0.3mg Tablet is a combination of two antidiabetic medicines: Repaglinide and voglibose. Repaglinide is a meglitinide analogue which increases the amount of insulin released by the pancreas. Voglibose is an alpha-glucosidase inhibitor which inhibits the intestinal enzymes that cause breakdown of complex sugars into simple sugars such as glucose. Together, they prevent blood sugar from rising very high after meals.
Related Warnings
Taking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.
Volga R 0.5mg/0.3mg Tablet may be unsafe to use during pregnancy.
Animal studies have shown adverse effects on the foetus, however, there are limited human studies. The benefits from use in pregnant women may be acceptable despite the risk. Please consult your doctor.
Volga R 0.5mg/0.3mg Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby.
Your ability to drive may be affected if your blood sugar is low or high. If this happens, do not drive.
Volga R 0.5mg/0.3mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Volga R 0.5mg/0.3mg Tablet may be needed. Please consult your doctor.
Volga R 0.5mg/0.3mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Volga R 0.5mg/0.3mg Tablet may be needed. Please consult your doctor.
Use of Volga R 0.5mg/0.3mg Tablet is not recommended in patients with severe liver disease.
